ArticleBMJ paediatrics open2025
Whole blood lead concentrations in children undergoing autism assessment in a community paediatric clinic: a retrospective cross-sectional study.
Article in BMJ paediatrics open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pica, avoidant restrictive food intake disorder and rumination disorder in children and adolescents with autism spectrum disorder: A systematic review.Journal of eating disorders · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate blood lead concentrations (BLCs) in children presenting with autistic spectrum disorder (ASD) and associations with clinical presentation (pica, motor delay, language delay and anaemia), age and social deprivation.
settingCommunity-based autism assessment clinics, north Bristol, UK (single-centre, retrospective cross-sectional study). PATIENTS: Children with autism who had BLC measured as part of an autism assessment during a 4-year period from November 2019 to November 2023.
main outcome measuresData were collected from electronic case notes for children who underwent an assessment for ASD during this period, including diagnoses and investigations.
results13/102 (13%) children with a diagnosis of autism had BLC ≥0.24 µmol/L, which is above the UK Health Security Agency threshold to trigger further investigation and identification of sources of exposure. Elevated BLC was not associated with the presence of pica or other clinical features including developmental delay.
conclusionPica and developmental delay were not useful indicators of children with elevated BLC. Their absence could lead to cases of elevated BLC being missed in children with autism. This lends weight to an argument that lead should be screened for routinely in the preschool autism population alongside other common causes of behavioural difficulties and developmental delay such as anaemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.